SPO11
gene geneOn this page
Also known as CT35SPATA43TOPVIATOPOVIA
Summary
SPO11 (SPO11 initiator of meiotic double strand breaks, HGNC:11250) is a protein-coding gene on chromosome 20q13.31, encoding Meiotic recombination protein SPO11 (Q9Y5K1). Component of a topoisomerase 6 complex specifically required for meiotic recombination.
Meiotic recombination and chromosome segregation require the formation of double-strand breaks (DSBs) in paired chromosome homologs. During meiosis in yeast, a meiotic recombination protein is covalently-linked to the 5’ end of DSBs and is essential for the formation of DSBs. The protein encoded by this gene is similar in sequence and conserved features to the yeast meiotic recombination protein. The encoded protein belongs to the TOP6A protein family. Several transcript variants encoding different isoforms have been found for this gene, but the full-length nature of only two of them have been described.
Source: NCBI Gene 23626 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 43 total — 1 likely-pathogenic
- MANE Select transcript:
NM_012444
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:11250 |
| Approved symbol | SPO11 |
| Name | SPO11 initiator of meiotic double strand breaks |
| Location | 20q13.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CT35, SPATA43, TOPVIA, TOPOVIA |
| Ensembl gene | ENSG00000054796 |
| Ensembl biotype | protein_coding |
| OMIM | 605114 |
| Entrez | 23626 |
Gene structure
Transcript identifiers
Ensembl transcripts: 5 — 4 protein_coding, 1 nonsense_mediated_decay
ENST00000345868, ENST00000371260, ENST00000371263, ENST00000418127, ENST00000494972
RefSeq mRNA: 2 — MANE Select: NM_012444
NM_012444, NM_198265
CCDS: CCDS13456, CCDS13457
Canonical transcript exons
ENST00000371263 — 13 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000511006 | 57333188 | 57333276 |
| ENSE00000662928 | 57331833 | 57331946 |
| ENSE00000662934 | 57335798 | 57335907 |
| ENSE00000845732 | 57333687 | 57333753 |
| ENSE00000845733 | 57333987 | 57334095 |
| ENSE00000845734 | 57334750 | 57334836 |
| ENSE00000845735 | 57335419 | 57335455 |
| ENSE00000845737 | 57338276 | 57338375 |
| ENSE00000845739 | 57340102 | 57340178 |
| ENSE00001431668 | 57329803 | 57329998 |
| ENSE00003503100 | 57342729 | 57342840 |
| ENSE00003784511 | 57338989 | 57339026 |
| ENSE00003889039 | 57343341 | 57343993 |
Expression profiles
Bgee: expression breadth broad, 20 present calls, max score 92.48.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0075 / max 7.6684, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 185465 | 0.0075 | 3 |
Top tissues by expression
272 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 92.48 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 87.99 | gold quality |
| right testis | UBERON:0004534 | 74.54 | gold quality |
| left testis | UBERON:0004533 | 72.93 | gold quality |
| testis | UBERON:0000473 | 72.36 | gold quality |
| secondary oocyte | CL:0000655 | 58.49 | silver quality |
| adult organism | UBERON:0007023 | 53.00 | gold quality |
| lower lobe of lung | UBERON:0008949 | 49.56 | silver quality |
| Brodmann (1909) area 46 | UBERON:0006483 | 49.30 | gold quality |
| blood vessel layer | UBERON:0004797 | 49.29 | gold quality |
| cervix squamous epithelium | UBERON:0006922 | 49.20 | gold quality |
| hair follicle | UBERON:0002073 | 49.18 | gold quality |
| olfactory bulb | UBERON:0002264 | 48.92 | gold quality |
| quadriceps femoris | UBERON:0001377 | 48.90 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 48.89 | gold quality |
| myocardium | UBERON:0002349 | 48.87 | gold quality |
| type B pancreatic cell | CL:0000169 | 48.83 | gold quality |
| oviduct epithelium | UBERON:0004804 | 48.73 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 48.56 | gold quality |
| tibialis anterior | UBERON:0001385 | 48.55 | silver quality |
| cardiac muscle of right atrium | UBERON:0003379 | 48.55 | gold quality |
| CA1 field of hippocampus | UBERON:0003881 | 48.50 | gold quality |
| vastus lateralis | UBERON:0001379 | 48.44 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 48.24 | gold quality |
| orbitofrontal cortex | UBERON:0004167 | 48.20 | gold quality |
| upper arm skin | UBERON:0004263 | 48.06 | gold quality |
| cervix epithelium | UBERON:0004801 | 48.04 | gold quality |
| tongue squamous epithelium | UBERON:0006919 | 47.92 | gold quality |
| mucosa of urinary bladder | UBERON:0001259 | 47.80 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 47.70 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.76 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
47 targeting SPO11, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-1277-5P | 100.00 | 73.95 | 5056 |
| HSA-MIR-5692B | 100.00 | 71.32 | 2622 |
| HSA-MIR-5692C | 100.00 | 71.32 | 2622 |
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-568 | 99.98 | 69.86 | 2084 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-374A-5P | 99.90 | 71.34 | 2923 |
| HSA-MIR-374B-5P | 99.90 | 69.98 | 2734 |
| HSA-MIR-579-3P | 99.86 | 71.66 | 3628 |
| HSA-MIR-664B-3P | 99.84 | 71.65 | 3590 |
| HSA-MIR-1323 | 99.83 | 69.89 | 2471 |
| HSA-MIR-2052 | 99.79 | 69.37 | 2031 |
| HSA-MIR-6885-3P | 99.75 | 70.36 | 3187 |
| HSA-MIR-548O-3P | 99.74 | 69.30 | 2228 |
| HSA-MIR-518A-5P | 99.70 | 69.01 | 2209 |
| HSA-MIR-527 | 99.70 | 69.01 | 2209 |
| HSA-MIR-379-3P | 99.69 | 69.60 | 1524 |
| HSA-MIR-411-3P | 99.69 | 69.63 | 1524 |
| HSA-MIR-548BA | 99.69 | 69.14 | 1514 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-3128 | 99.50 | 67.85 | 1258 |
| HSA-MIR-183-3P | 99.41 | 69.41 | 1598 |
Literature-anchored findings (GeneRIF, showing 7)
- Mutations in the human SPO11 gene are not common causes of infertility in man (PMID:16169419)
- Data show that there is no association between SPO11 gene mutation and premature ovarian failure. (PMID:18166824)
- SPO11 might has an effect on premorbid functioning, which increase susceptibility for idiopathic male reproduction (PMID:21556891)
- Polymorphisms within the SPO11 gene are linked to the susceptibility of azoospermia and oligozoospermia male infertility. (PMID:25005169)
- Data suggest that the combined genotypes of glutathionine S-transferase GSTM1 (-/-), GSTT1 (+/+), GSTP1 (AA) and meiotic recombination protein SPO11 (CT) may be associated with idiopathic male infertility in ethnic Han Chinese. (PMID:26663067)
- SPO11 gene C631T polymorphism may contribute as a genetic factor susceptible to cause male infertility in Chinese. (PMID:28050928)
- Centromeres are dismantled by foundational meiotic proteins Spo11 and Rec8. (PMID:33658710)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | spo11 | ENSDARG00000013837 |
| mus_musculus | Spo11 | ENSMUSG00000005883 |
| rattus_norvegicus | Spo11 | ENSRNOG00000006732 |
| drosophila_melanogaster | mei-W68 | FBGN0002716 |
| caenorhabditis_elegans | WBGENE00004985 |
Protein
Protein identifiers
Meiotic recombination protein SPO11 — Q9Y5K1 (reviewed: Q9Y5K1)
Alternative names: Cancer/testis antigen 35
All UniProt accessions (4): Q9Y5K1, H0YCK9, Q5TCH6, Q5TCH7
UniProt curated annotations — full annotation on UniProt →
Function. Component of a topoisomerase 6 complex specifically required for meiotic recombination. Together with TOP6BL, mediates DNA cleavage that forms the double-strand breaks (DSB) that initiate meiotic recombination. The complex promotes relaxation of negative and positive supercoiled DNA and DNA decatenation through cleavage and ligation cycles. Essential for the phosphorylation of SMC3, HORMAD1 and HORMAD2.
Subunit / interactions. Heterotetramer of SPO11 and 2 TOP6BL chains. Interacts with TOP6BL.
Subcellular location. Nucleus.
Tissue specificity. Highly expressed in testis.
Similarity. Belongs to the TOP6A family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q9Y5K1-1 | 1 | yes |
| Q9Y5K1-2 | 2 |
RefSeq proteins (2): NP_036576, NP_937998 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR002815 | Spo11/TopoVI_A | Family |
| IPR004084 | Meiosis_Spo11 | Domain |
| IPR013048 | Meiotic_Spo11 | Family |
| IPR013049 | Spo11/TopoVI_A_N | Domain |
| IPR034136 | TOPRIM_Topo6A/Spo11 | Domain |
| IPR036078 | Spo11/TopoVI_A_sf | Homologous_superfamily |
| IPR036388 | WH-like_DNA-bd_sf | Homologous_superfamily |
Pfam: PF03533, PF04406, PF21180
UniProt features (10 total): sequence variant 4, binding site 2, chain 1, domain 1, active site 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9Y5K1-F1 | 91.12 | 0.80 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Catalytic / active sites (1): 138 (o-(5’-phospho-dna)-tyrosine intermediate)
Ligand- & substrate-binding residues (2): 224; 277
Function
Pathways and Gene Ontology
Reactome pathways
4 pathways
| ID | Pathway |
|---|---|
| R-HSA-912446 | Meiotic recombination |
| R-HSA-1474165 | Reproduction |
| R-HSA-1500620 | Meiosis |
| R-HSA-1640170 | Cell Cycle |
MSigDB gene sets: 187 (showing top):
GOBP_MEIOTIC_CHROMOSOME_SEGREGATION, REACTOME_MEIOTIC_RECOMBINATION, GOBP_CHROMOSOME_ORGANIZATION, GOBP_CHROMOSOME_LOCALIZATION, GOBP_OOGENESIS, GOBP_MALE_GAMETE_GENERATION, KAUFFMANN_DNA_REPAIR_GENES, GOBP_SYNAPTONEMAL_COMPLEX_ORGANIZATION, TCF4_Q5, GOBP_OVARIAN_FOLLICLE_DEVELOPMENT, GOBP_ORGANELLE_FISSION, GOBP_REPRODUCTIVE_SYSTEM_DEVELOPMENT, GOBP_PROTEIN_LOCALIZATION_TO_CHROMOSOME, GOBP_DNA_DAMAGE_RESPONSE, GOBP_MALE_MEIOSIS_I
GO Biological Process (16): meiotic DNA double-strand break processing (GO:0000706), ovarian follicle development (GO:0001541), synaptonemal complex assembly (GO:0007130), reciprocal meiotic recombination (GO:0007131), male meiosis I (GO:0007141), spermatogenesis (GO:0007283), spermatid development (GO:0007286), female gamete generation (GO:0007292), protein localization to chromosome (GO:0034502), meiotic DNA double-strand break formation (GO:0042138), meiotic telomere clustering (GO:0045141), oogenesis (GO:0048477), double-strand break repair involved in meiotic recombination (GO:1990918), DNA metabolic process (GO:0006259), homologous chromosome pairing at meiosis (GO:0007129), meiotic cell cycle (GO:0051321)
GO Molecular Function (8): DNA binding (GO:0003677), DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity (GO:0003918), ATP binding (GO:0005524), metal ion binding (GO:0046872), catalytic activity (GO:0003824), DNA topoisomerase activity (GO:0003916), protein binding (GO:0005515), isomerase activity (GO:0016853)
GO Cellular Component (4): nuclear chromosome (GO:0000228), chromosome, telomeric region (GO:0000781), nucleus (GO:0005634), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-3 pathways:
| Category | Pathways |
|---|---|
| Meiosis | 1 |
| Reproduction | 1 |
| Cell Cycle | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| meiotic cell cycle process | 3 |
| chromosome organization involved in meiotic cell cycle | 3 |
| meiotic cell cycle | 2 |
| meiosis I | 2 |
| male gamete generation | 2 |
| germ cell development | 2 |
| DNA double-strand break processing | 1 |
| female gonad development | 1 |
| anatomical structure development | 1 |
| homologous chromosome pairing at meiosis | 1 |
| cellular component assembly | 1 |
| synaptonemal complex organization | 1 |
| reciprocal homologous recombination | 1 |
| male meiotic nuclear division | 1 |
| developmental process involved in reproduction | 1 |
| spermatid differentiation | 1 |
| gamete generation | 1 |
| protein localization to organelle | 1 |
| DNA metabolic process | 1 |
| meiosis I cell cycle process | 1 |
| telomere localization | 1 |
| chromosome localization to nuclear envelope involved in homologous chromosome segregation | 1 |
| female gamete generation | 1 |
| double-strand break repair | 1 |
| reciprocal meiotic recombination | 1 |
| nucleic acid metabolic process | 1 |
| homologous chromosome segregation | 1 |
| cell cycle | 1 |
| sexual reproduction | 1 |
| reproductive process | 1 |
| meiotic nuclear division | 1 |
| nucleic acid binding | 1 |
| DNA topoisomerase activity | 1 |
| ATP-dependent activity, acting on DNA | 1 |
| adenyl ribonucleotide binding | 1 |
| purine ribonucleoside triphosphate binding | 1 |
| cation binding | 1 |
| molecular_function | 1 |
| DNA binding | 1 |
| nucleic acid conformation isomerase activity | 1 |
Protein interactions and networks
STRING
2118 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPO11 | TOP6BL | Q8N6T0 | 986 |
| SPO11 | REC8 | O95072 | 907 |
| SPO11 | HORMAD1 | Q86X24 | 897 |
| SPO11 | RAD51 | Q06609 | 893 |
| SPO11 | MEI1 | Q5TIA1 | 881 |
| SPO11 | MSH4 | O15457 | 875 |
| SPO11 | PRDM9 | Q9NQV7 | 871 |
| SPO11 | SKIC8 | Q9GZS3 | 868 |
| SPO11 | REC114 | Q7Z4M0 | 866 |
| SPO11 | MSH5 | O43196 | 845 |
| SPO11 | SYCP3 | Q8IZU3 | 844 |
| SPO11 | EXO1 | Q9UQ84 | 843 |
| SPO11 | SLC39A1 | Q9NY26 | 838 |
| SPO11 | HORMAD2 | Q8N7B1 | 815 |
| SPO11 | RNF212 | Q495C1 | 813 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SPO11 | TUBB8 | psi-mi:“MI:0915”(physical association) | 0.400 |
| ATF1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
| CEBPA | SAP18 | psi-mi:“MI:0914”(association) | 0.350 |
| STAT3 | NACA | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (3): SPO11 (Affinity Capture-MS), TCF4 (Two-hybrid), TUBB8 (Affinity Capture-MS)
ESM2 similar proteins: A0A0U1RQE8, A3BLS0, B2RXZ1, B6DMK2, O22190, O24357, O81829, O82243, O82333, O82504, P0C0M2, P0C0M3, Q0D4Z6, Q16P87, Q28CZ9, Q3EBC8, Q43839, Q4V8A1, Q4V8Q1, Q502J0, Q5R6R6, Q654M1, Q655R6, Q6J756, Q6QR59, Q6ZLA3, Q6ZLA7, Q7L7V1, Q7TS68, Q8GZ29, Q8LGM7, Q8LQM5, Q8NA58, Q969I3, Q9C5X8, Q9D5U0, Q9FZ87, Q9LND7, Q9LQ68, Q9LSQ4
Diamond homologs: A2BLE8, A2XFC1, B0R4D2, O05208, O27089, O29322, O59209, P40384, Q0DSV9, Q2QM00, Q3IPW7, Q57815, Q5JH82, Q5V4R4, Q5ZPI9, Q5ZPV8, Q6ZD95, Q7KPA5, Q7Y021, Q8TQF8, Q8U0K9, Q971T1, Q9HR32, Q9LZ03, Q9M4A1, Q9M4A2, Q9WTK8, Q9Y5K1, Q9YE67, C4VB43, P23179, Q22236, Q468I6, Q8PUB7, Q9V134, Q8SVS9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
43 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 1 |
| Uncertain significance | 39 |
| Likely benign | 1 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (1)
| Variant ID | HGVS | Classification |
|---|---|---|
| 1244233 | NM_012444.3(SPO11):c.744G>A (p.Thr248=) | Likely pathogenic |
SpliceAI
1935 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:57329927:G:GT | donor_gain | 1.0000 |
| 20:57331947:G:GG | donor_gain | 1.0000 |
| 20:57333168:T:TA | acceptor_gain | 1.0000 |
| 20:57333174:A:AG | acceptor_gain | 1.0000 |
| 20:57333175:A:G | acceptor_gain | 1.0000 |
| 20:57333178:A:AG | acceptor_gain | 1.0000 |
| 20:57333178:AAAAT:A | acceptor_gain | 1.0000 |
| 20:57333179:A:G | acceptor_gain | 1.0000 |
| 20:57333180:A:AG | acceptor_gain | 1.0000 |
| 20:57333272:ATTTT:A | donor_gain | 1.0000 |
| 20:57333273:TTTT:T | donor_gain | 1.0000 |
| 20:57333274:TTT:T | donor_gain | 1.0000 |
| 20:57333275:TT:T | donor_gain | 1.0000 |
| 20:57333277:G:GG | donor_gain | 1.0000 |
| 20:57333983:ATAG:A | acceptor_gain | 1.0000 |
| 20:57333983:ATAGG:A | acceptor_gain | 1.0000 |
| 20:57334092:TATA:T | donor_gain | 1.0000 |
| 20:57334093:ATA:A | donor_gain | 1.0000 |
| 20:57334094:TA:T | donor_gain | 1.0000 |
| 20:57334095:AGTAA:A | donor_loss | 1.0000 |
| 20:57334096:G:GG | donor_gain | 1.0000 |
| 20:57334096:GT:G | donor_loss | 1.0000 |
| 20:57334097:TAAGT:T | donor_loss | 1.0000 |
| 20:57334098:AAGTA:A | donor_loss | 1.0000 |
| 20:57334747:CA:C | acceptor_loss | 1.0000 |
| 20:57334748:A:AG | acceptor_gain | 1.0000 |
| 20:57334748:AGTT:A | acceptor_loss | 1.0000 |
| 20:57334749:G:GG | acceptor_gain | 1.0000 |
| 20:57334749:GT:G | acceptor_gain | 1.0000 |
| 20:57334749:GTT:G | acceptor_gain | 1.0000 |
AlphaMissense
2613 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:57335837:A:T | K225I | 0.999 |
| 20:57334765:G:C | G176R | 0.997 |
| 20:57335834:A:T | E224V | 0.997 |
| 20:57338277:G:A | G249E | 0.996 |
| 20:57338305:A:C | R258S | 0.996 |
| 20:57338305:A:T | R258S | 0.996 |
| 20:57338362:T:A | D277E | 0.996 |
| 20:57338362:T:G | D277E | 0.996 |
| 20:57340147:T:A | W310R | 0.996 |
| 20:57340147:T:C | W310R | 0.996 |
| 20:57335858:T:C | L232P | 0.995 |
| 20:57343452:T:A | W395R | 0.995 |
| 20:57343452:T:C | W395R | 0.995 |
| 20:57333987:G:C | R134S | 0.994 |
| 20:57333987:G:T | R134S | 0.994 |
| 20:57334766:G:A | G176D | 0.994 |
| 20:57338276:G:A | G249R | 0.994 |
| 20:57338276:G:C | G249R | 0.994 |
| 20:57338289:C:A | P253H | 0.994 |
| 20:57338361:A:T | D277V | 0.994 |
| 20:57335842:G:C | A227P | 0.993 |
| 20:57338277:G:T | G249V | 0.993 |
| 20:57338360:G:C | D277H | 0.993 |
| 20:57339019:G:A | G292E | 0.993 |
| 20:57343371:G:C | A368P | 0.993 |
| 20:57343436:A:C | K389N | 0.993 |
| 20:57343436:A:T | K389N | 0.993 |
| 20:57335835:A:C | E224D | 0.992 |
| 20:57335835:A:T | E224D | 0.992 |
| 20:57338304:G:C | R258T | 0.992 |
dbSNP variants (sampled 300 via entrez): RS1000010226 (20:57337785 A>G), RS1000148419 (20:57343889 T>C), RS1000177783 (20:57331285 C>T), RS1000232361 (20:57330008 C>G), RS1000372374 (20:57336673 T>C), RS1000565163 (20:57328986 G>A,T), RS1000842706 (20:57331613 G>A,C), RS1000853131 (20:57342198 T>A), RS1001278523 (20:57331037 T>A), RS1001374166 (20:57337949 G>A), RS1001647840 (20:57331330 G>C), RS1001737200 (20:57339758 A>G), RS1001853579 (20:57343991 G>A), RS1002340704 (20:57328748 C>A,T), RS1002443418 (20:57334583 A>T)
Disease associations
OMIM: gene MIM:605114 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST90002383_303 | Hematocrit | 1.000000e-12 |
| GCST90002384_475 | Hemoglobin | 3.000000e-10 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004348 | hematocrit |
| EFO:0004509 | hemoglobin measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
6 total (human), top 6 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Benzo(a)pyrene | increases expression, increases methylation | 2 |
| bisphenol A | increases expression | 1 |
| Valproic Acid | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Sodium Selenite | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.